Identity
- Trade Name
- LIDBLEF INTENSIVE CARE EUDAMED
- Device Name
- NAVIBLEF TERP INTENSIVE CARE EUDAMED
- Model / Reference
- F50NTI EUDAMED
Identifiers
- Primary DI / UDI-DI
- D-F50NTI6C EUDAMED
- Basic UDI-DI
- B-F50NTI6C EUDAMED
- EMDN Code
- Q0299 OPHTHALMIC DEVICES - OTHER EUDAMED
Classification
- Device Class
- Class IIa EUDAMED
- Market of Registration
- Greece EUDAMED
Clinical & Handling
Sterile
No
EUDAMED
Implantable
No
EUDAMED
Reusable
No
EUDAMED
Contains Latex
No
EUDAMED
Reprocessed
No
EUDAMED
Human-derived
No
EUDAMED
Human Tissues
No
EUDAMED
Animal Tissues
No
EUDAMED
Administering Medicine
No
EUDAMED
Measuring Function
No
EUDAMED
Incorporates Medicinal Product
No
EUDAMED
Lidblef Intensive Care by Novax Pharma SAM — Class IIa — MDD — listed in EUDAMED — regulatory data on deviCERTS
Authorization Coverage (European Union — 27 member states)
Regulatory Authorizations
European Union Active
CE/MDD
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| EUDAMED | European Union | CE/MDD | B-F50NTI6C | Class IIa | Active |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Novax Pharma SAM
- EUDAMED SRN
- MC-MF-000011256
- Authorised Representative
- International Associates Auditing & Certification Limited IE-AR-000002248
Sources (1)
- EUDAMED 8ca1170c-3837-4161-ab81-9b9e2011ff7a 61 fields · synced Jun 18, 2026